[1] Geleijnse, J.M., Vermeer, C., Grobee, D.E., Schurgers, L.J., Knapen, M.H.J., van der Meer, I.M., et al. (2004) Dietary Intake of Menaquinone Is Associated with a Reduced Risk of Coronary Heart Disease: The Rotterdam Study. Journal of Nutrition, 134, 3100-3105.
[2] Beulens, J.W.J., Bots, M.L., Atsma, F., Bartelink, M.-A.E.L., Procop, M., Geleijnse, J.M., et al. (2008) High Dietary Menaquinone Intake Is Associated with Reduced Coronary Calcification. Atherosclerosis, 203, 489-493.
http://dx.doi.org/10.1016/j.atherosclerosis.2008.07.010
[3] Gast, G.C.M., de Roos, N.M., Bots, M.L., Beulens, J.W.J., Geleijnse, J.M., Witteman, J.C., et al. (2009) High Menaquinone Intake Reduces the Incidence of Coronary Heart Disease. Nutrition, Metabolism and Cardiovascular Diseases, 19, 504-507.
http://dx.doi.org/10.1016/j.numecd.2008.10.004
[4] Danzinger, J. (2008) Vitamin K-Dependent Proteins, Warfarin, and Vascular Calcification. Clinical Journal of the American Society of Nephrology, 3, 1504-1510.
http://dx.doi.org/10.2215/CJN.00770208
[5] Chatrou, M.L.L., Winkers, K., Hackeng, T.M., Reutelingsperger, C.P. and Schurgers, L.J. (2012) Vascular Calcification: The Price to Pay for Anticoagulation Therapy with Vitamin K-Antagonists. Blood Reviews, 26, 155-166.
http://dx.doi.org/10.1016/j.blre.2012.03.002
[6] Zhang, Y.-T. and Tang, Z.-Y. (2014) Research Progress of Warfarin-Associated Vascular Calcification and Its Possible Therapy. Cardiovascular Pharmacology, 63, 76-82.
http://dx.doi.org/10.1097/FJC.0000000000000008
[7] Price, P.A., Faus, S.A. and Williamson, M.K. (1998) Warfarin Causes Rapid Calcification of the Elastic Lamellae in Rat Arteries and Heart Valves. Arteriosclerosis, Thrombosis, and Vascular Biology, 18, 1400-1407.
http://dx.doi.org/10.1161/01.ATV.18.9.1400
[8] Howe, A.M. and Webster, W.S. (2000) Warfarin Exposure and Calcification of the Arterial System of the Rat. International Journal of Experimental Pathology, 81, 51-56.
http://dx.doi.org/10.1046/j.1365-2613.2000.00140.x
[9] Spronk, H.M.H., Soute, B.A.M., Schungers, L.J., Thijssen, H.H.W., De Mey, J.G.R. and Vermeer, C. (2003) Tisssue-Specific Utilization of Menaquinone-4 Results in the Prevention of Arterial Calcification in Warfarin-Treated Rats. Journal of Vascular Research, 40, 531-537.
http://dx.doi.org/10.1159/000075344
[10] Dao, H.H., Essalihi, R., Graillon, J.-F., Lariviere, R., de Champlain, J. and Moreau, P. (2002) Pharmacological Prevention and Regression of Arterial Remodeling in a Rat Model of Isolated Systolic Hypertension. Journal of Hypertension, 20, 1597-1606.
http://dx.doi.org/10.1097/00004872-200208000-00023
[11] Schungers, L.J., Spronk, H.M.H., Soute, B.A.M., Schiffers, P.M., De Mey, J.G.R. and Vermeer, C. (2007) Regression of Warfarin-Induced Medial Elastocalcinosis by High Intake of Vitamin K in Rats. Blood, 109, 2823-2831.
http://dx.doi.org/10.1182/blood-2006-07-035345
[12] Beazley, K.E., Banyard, D., Lima, F., Deasey, S.C., Nurminsky, D.I., Konoplyannikov, M. and Nurminskay, M.V. (2013) Transglutaminase Inhibitors Attenuate Vascular Calcification in a Preclinical Model. Arteriosclerosis, Thrombosis, and Vascular Biology, 33, 43-51.
http://dx.doi.org/10.1161/ATVBAHA.112.300260
[13] Rubin, M.R. and Silverberg, S.J. (2004) Vascular Calcification and Osteoporosis—The Nature of the Nexus. The Journal of Clinical Endocrinology and Metabolism, 89, 4243-4245.
http://dx.doi.org/10.1210/jc.2004-1324
[14] Binkley, N., Krueger, D., Engelke, J. and Suttle, J. (2007) Vitamin K Deficiency from Long-Term Warfarin Anticoagulation Does Not Alter Skeletal Status in Male Rhesus Monkeys. Journal of Bone and Mineral Research, 22, 695-700.
http://dx.doi.org/10.1359/jbmr.070208
[15] Sokol’nikov, A.A., Kodentsova, V.M., Sergeev, I.N. Strunin, S.E. and Sklimov, O.A. (1989) Calcium Metabolism in the Case of Vitamin D and K Deficiencies. Voprosy Pitaniia, 1, 56-60.
[16] Payne, R.B., Little, A.J., Williams, R.B. and Milner, J.R. (1973) Interpretation of Serum Calcium in Patients with Abnormal Serum Proteins. British Medical Journal, 4, 643-646.
http://dx.doi.org/10.1136/bmj.4.5893.643
[17] Cheung, C.L., Sahni, S., Cheung, B.M., Sing, C.W. and Wong, I.C. (2014) Vitamin K Intake and Mortality in People with Chronic Disease from NHANES III. Clinical Nutrition, in Press.
http://dx.doi.org/10.1016/j.clnu.2014.03.011
[18] Ferland, G. (1998) The Vitamin K-Dependent Proteins: An Update. Nutrition Reviews, 56, 223-230.
http://dx.doi.org/10.1111/j.1753-4887.1998.tb01753.x
[19] Luo, G., Ducy, P., McKee, M.D., Pinero, G.J., Loyer, E., Behringer, R.R. and Karsenty, G. (1997) Spontaneous Calcification of Arteries and Cartilage in Mice Lacking Matrix GLA Protein. Nature, 386, 78-81.
http://dx.doi.org/10.1038/386078a0
[20] Erkkil?, A.T. and Booth, S.L. (2008) Vitamin K Intake and Atherosclerosis. Current Opinion in Lipidology, 19, 39-42.
http://dx.doi.org/10.1097/MOL.0b013e3282f1c57f
[21] Demer, L.L. and Tintut, Y. (2014) Inflammatory, Metabolic and Genetic Mechanisms of Vascular Calcification. Arteriosclerosis, Thrombosis, and Vascular Biology, 34, 715-723.
http://dx.doi.org/10.1161/ATVBAHA.113.302070
[22] Frye, M.A., Melton III, L.J., Bryant, S.C., Fitzpatrick, L.A., Wahner, H.V.V., Schwartz, R.S. and Riggs, B.L. (1992) Osteoporosis and Calcification of the Aorta. Bone and Mineral, 19, 185-194.
http://dx.doi.org/10.1016/0169-6009(92)90925-4
[23] Szulc, P., Kiel, D.P. and Delmas, P.D. (2008) Calcifi-cations in the Abdominal Aorta Predict Fractures in Men: MINOS Study. Journal of Bone and Mineral Research, 23, 95-102.
http://dx.doi.org/10.1359/jbmr.070903
[24] Naves, M., Rodriguez-Garcia, M., Diaz-López, J.B. Gómez-Alonso, C. and Cannata-Andia, J.B. (2008) Progression of Vascular Calcifications Is Associated with Greater Bone Loss and Increased Bone-Fractures. Osteoporosis International, 19, 1161-1166.
http://dx.doi.org/10.1007/s00198-007-0539-1
[25] Siltari, A., Wickholm, N., Kivimäki, A.S., Olli, K., Salli, K., Tiihonen, K., Korpela, R. and Vapaatalo, H. (2014) Effects of Vitamin K-1 and Menaquinone-7 on Vascular Function and Blood Pressure in Warfarin-Induced Calcification-Model in Rats. Pharmacology & Pharmacy, 5, 1095-1105.
http://dx.doi.org/10.4236/pp.2014.512119